Daily Medical News

Latest Episodes:

Experts advocate for flu vaccination Sep 28, 2018

Show notes

The National Foundation for Infectious Diseases advocates for vaccination for influenza (http://bit.ly/2N8ZRXE). Also today, the U.S. House and Senate agree on a broad opioid legislation (http://bit.ly/2OQ9lsh), a computerized tool could ease decision-making for lupus (http://bit.ly/2xXRrwA), and a proposed change to Part B drug reimbursement draws more fire from physician organizations (http://bit.ly/2QgYS9T).

America's gabapentin problem Sep 27, 2018

Show notes

Signs point to growing abuse of gabapentinoids in the United States. Short sleep is linked to elevated blood pressure. Another large trial shows CT screening reduces lung cancer deaths. And atrial fibrillation guidelines may miss the mark with oral anticoagulation.

ADHD: The big picture Sep 26, 2018

Show notes

A pediatric psychiatric consult for adolescent and adult ADHD by Sarah E. Guth, MD (http://bit.ly/2IiA6Dy). Also today, prosthesis-patient mismatch post TAVR ups the risk of death by 19% (http://bit.ly/2zshtdw), residents help to curb the overuse of IV antibiotics in children (http://bit.ly/2IhySsg), and both age and other risk factors ought to guide chlamydia and gonorrhea screening for women infected with HIV (http://bit.ly/2ztaT6E).

You can subscribe to the Postcall Podcast ahead of the first episode (https://apple.co/2IeKD2y)

Ketamine for pain syndromes Sep 25, 2018

Show notes

Ketamine may be helpful in central sensitization pain syndromes (http://bit.ly/2O5TN6F). Also today, trifarotene cream for acne meats all endpoints in twin phase 3 trials (http://bit.ly/2xJ5GGz), the pros and cons of gastric bypass surgery for patients with type 2 diabetes (http://bit.ly/2OOam4m), and it looks like obesity plays a role in sleep-disordered breathing for pregnant women (http://bit.ly/2px9yWr).

A hidden bonus for rivaroxaban? Sep 24, 2018

Show notes

Bleeding from rivaroxaban may help diagnose some GI and GU cancers (http://bit.ly/2O6YfCf [Cardiocast: http://bit.ly/2xJNOdv]). Also today, a review by the FDA supports the safety of nuplazid (http://bit.ly/2pxT5Bw), arthritis is prevalent in older adults with any degree of depression (http://bit.ly/2xxTXug), and growth in overdose deaths is exponential (http://bit.ly/2xIHG5xf).

What you should know about celiac disease Sep 21, 2018

Show notes

Dr. Joseph Murray of the Mayo Clinic points out that you might know as much about celiac as you think (http://bit.ly/2preFr4).

Also today, a novel agent shows unprecedented efficacy in psoriasis (http://bit.ly/2MLLE2I), IgA vasculitis may be more common in adults than you think (http://bit.ly/2DeXTFC), and one-step gestational diabetes screening doesn't improve outcomes (http://bit.ly/2xy7VLM).

Behavioral intervention in obese adults Sep 20, 2018

Show notes

The U.S. Preventative Services Task Force advises clinicians to refer or offer intensive behavioral weight-loss interventions to obese adults (http://bit.ly/2DbYO9F). Also today, stop treating gout and start curing it (http://bit.ly/2QIhaBO) the FDA has a new risk evaluation mitigation strategy for immediate-release opioids (http://bit.ly/2Df9AvY), and the United Nations aims to eradicate tuberculosis by the year 2030 (http://bit.ly/2DenEFN).

Troubling MRI changes and pediatric hypertension Sep 19, 2018

Show notes

Researchers found evidence of impaired white matter integrity on MRI in a handful of hypertensive children similar to what is found in adults with cognitive impairment from hypertension (http://bit.ly/2NR9MWc). Also today, predictors for worse outcomes in low–disease activity RA remain tough to come by (http://bit.ly/2MMZ4M1), elevated type 2 diabetes risk seen in PsA patients (http://bit.ly/2NjOAZo), and new European hypertension guidelines target most adults to less than 130/80 mm Hg (http://bit.ly/2OAmLsv).

Alarming rate of diabetes medication discontinuations Sep 18, 2018

Show notes

Most patients with type 2 diabetes stop taking their medication within a year, and nearly one-third stop within the first 3 months (http://bit.ly/2QD0U4U). Also today, the FDA approves Ajovy for migraine prevention(http://bit.ly/2Nhbxwq), some teens are using cannabis in their vapor devices (http://bit.ly/2pekqs7), and alpha-blocker use is still common and still risky (http://bit.ly/2No2QAE).

Urine drugs screens show improper medication use Sep 17, 2018

Show notes

More than half of patients who were tested for prescription drug compliance last year misused their medications (http://bit.ly/2xpqou1). Also today, obesity prevalence is now at least 35% in 7 states(http://bit.ly/2NLI3WW), the FDA has a new plan to combat antibiotic resistance (http://bit.ly/2MCBykL), and what will come of all the comments about the new E/M payment proposals (http://bit.ly/2xryMZM).

Our TOPPODCAST Picks

Follow Us

Stay Connected

Related Podcasts

Links

Stay Connected